Correlation Between Enzo Biochem and BioMark Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and BioMark Diagnostics, you can compare the effects of market volatilities on Enzo Biochem and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and BioMark Diagnostics.

Diversification Opportunities for Enzo Biochem and BioMark Diagnostics

-0.07
  Correlation Coefficient

Good diversification

The 3 months correlation between Enzo and BioMark is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and BioMark Diagnostics go up and down completely randomly.

Pair Corralation between Enzo Biochem and BioMark Diagnostics

Considering the 90-day investment horizon Enzo Biochem is expected to under-perform the BioMark Diagnostics. In addition to that, Enzo Biochem is 1.07 times more volatile than BioMark Diagnostics. It trades about -0.01 of its total potential returns per unit of risk. BioMark Diagnostics is currently generating about 0.01 per unit of volatility. If you would invest  15.00  in BioMark Diagnostics on September 14, 2024 and sell it today you would earn a total of  0.00  from holding BioMark Diagnostics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

Enzo Biochem  vs.  BioMark Diagnostics

 Performance 
       Timeline  
Enzo Biochem 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Enzo Biochem are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
BioMark Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioMark Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Enzo Biochem and BioMark Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzo Biochem and BioMark Diagnostics

The main advantage of trading using opposite Enzo Biochem and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.
The idea behind Enzo Biochem and BioMark Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes